Congress Returns, Healthcare Hearings, Kennedy Testifies
Summary
McDermott+ Consulting published a weekly healthcare preview noting Congress has returned from recess with a full agenda focused on DHS funding and potential reconciliation legislation. HHS Secretary Robert F. Kennedy Jr. is scheduled to testify before three House committees regarding the President's FY 2027 HHS budget priorities. Multiple healthcare-related committee hearings are scheduled, including sessions on chronic disease prevention, healthcare innovation, fraud prevention in state-run programs, and public health legislation.
What changed
This document is a law firm weekly preview summarizing Congressional activity for the week of April 13, 2026. It discusses Congress returning from recess, upcoming healthcare hearings, and HHS Secretary Kennedy's testimony schedule regarding FY 2027 budget priorities.
Affected parties should monitor Congressional activity as multiple healthcare-related hearings are scheduled, including sessions on chronic disease prevention, fraud prevention in federally funded state programs, and public health legislation. HHS Secretary Kennedy's testimony may provide insight into the administration's FY 2027 healthcare policy priorities.
What to do next
- Monitor for updates
Archived snapshot
Apr 15, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
April 14, 2026
Healthcare Preview for the Week of: April 13, 2026
Debra Curtis, Erin Fuller, Maddie News, Rodney Whitlock Ph.D. McDermott+ + Follow Contact LinkedIn Facebook X Send Embed
They’re back: Congress returns to Washington
Congress’ two-week recess has officially ended, with the House returning tomorrow and the Senate back in session today. Both chambers are returning to full agendas, with attention focused on budget hearings, ongoing discussions around funding the Department of Homeland Security (DHS), and continued speculation about a potential “Reconciliation 2.0” package.
In the near term, much of the focus will be on whether the Senate takes steps to advance funding for Customs and Border Protection and Immigration and Customs Enforcement, potentially through a narrower reconciliation vehicle. The House, for its part, is not expected to take up DHS funding legislation this week, as leadership continues to wait for greater clarity on the viability and scope of a reconciliation package in the Senate before moving forward. We will be watching closely for any movement in the Senate.
Healthcare action will be centered at the committee level this week, where there are certainly no shortage of healthcare-related hearings. On Tuesday, the House Committee on Ways and Means’ Health Subcommittee will hold a hearing at the Lake Erie College of Osteopathic Medicine in Bradenton, Florida, on modernizing healthcare to improve chronic disease prevention and incentivizing healthcare innovation. On Wednesday, the House Committee on Oversight and Government Reform’s Government Operations Subcommittee will hold a hearing to discuss fraud prevention in state-run, federally funded programs, and the House Committee on Energy and Commence, Health Subcommittee will also hold a hearing to review public health legislation.
Department of Health and Human Services (HHS) Secretary Kennedy has a particularly big week, with plans to testify in front of three separate House committees as a champion of the president’s fiscal year (FY) 2027 budget priorities for HHS. Secretary Kennedy will testify in front of the House Ways and Means Committee at 9 am Thursday and then in an afternoon appearance at the House Appropriations Committee Labor HHS Subcommittee that same day, and wraps up with an appearance at the House Committee on Education and Workforce on Friday at 9 am.
On the regulatory front, we are still reviewing Friday’s release of the FY 2027 Medicare Hospital Inpatient Prospective Payment System (IPPS) and Long-Term Care Hospital (LTCH) Prospective Payment System (PPS) proposed rule and the Interoperability Standards and Prior Authorization for Drugs proposed rule, and continue to watch out for the federal independent dispute resolution operations rule and the Notice of Benefit and Payment Parameters for 2027.
[View source.]
Related Posts
- Healthcare Preview for the Week of: April 6, 2026
- Healthcare Preview for the Week of: March 23, 2026
- Healthcare Preview for the Week of: March 16, 2026
Latest Posts
DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.
Attorney Advertising.
©
McDermott+
Written by:
McDermott+ Contact + Follow Debra Curtis + Follow Erin Fuller + Follow Maddie News + Follow Rodney Whitlock Ph.D. + Follow more less
PUBLISH YOUR CONTENT ON JD SUPRA
- ✔ Increased readership
- ✔ Actionable analytics
- ✔ Ongoing writing guidance Join more than 70,000 authors publishing their insights on JD Supra
Published In:
Appropriations Bill + Follow Budget Reconciliation + Follow Centers for Medicare & Medicaid Services (CMS) + Follow Congressional Committees + Follow Department of Health and Human Services (HHS) + Follow Department of Homeland Security (DHS) + Follow Federal Budget + Follow Government Agencies + Follow Healthcare Fraud + Follow Healthcare Reform + Follow Inpatient Prospective Payment System (IPPS) + Follow Legislative Agendas + Follow Medicare + Follow Proposed Rules + Follow Public Health + Follow Regulatory Oversight + Follow Administrative Agency + Follow Health + Follow Insurance + Follow more less
McDermott+ on:
"My best business intelligence, in one easy email…"
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Sign Up Log in ** By using the service, you signify your acceptance of JD Supra's Privacy Policy.* - hide - hide
Related changes
Get daily alerts for JD Supra Healthcare
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from McDermott+.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when JD Supra Healthcare publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.